Pulmonary arterial hypertension associated to human immunodeficiency virus

被引：1

作者：

Luis Sandoval-Gutierrez, Jose ^{[1
]}

Efren Santos-Martinez, Luis ^{[2
]}

Rodriguez-Silverio, Juan ^{[3
]}

Martin Baranda-Tovar, Francisco ^{[4
]}

Maria Rivera-Rosales, Rosa ^{[5
]}

Javier Flores-Murrieta, Francisco ^{[3
]}

机构：

[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Urgencias Resp, Secretaria Salubridad & Asistencia, Mexico City, DF, Mexico

[2] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, UMAE Hosp Cardiol, Dept Hipertens Pulmonar & Func Ventricular Derech, Mexico City, DF, Mexico

[3] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Secretaria Salubridad & Asistencia, Dept Farmacol, Mexico City, DF, Mexico

[4] Inst Nacl Cardiol Ignacio Chavez, Secretaria Salubridad & Asistencia, Dept Cuidados Intens Posquirurg Cardiovasc, Mexico City, DF, Mexico

[5] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Secretaria Salubridad & Asistencia, Dept Patol, Mexico City, DF, Mexico

来源：

ARCHIVOS DE CARDIOLOGIA DE MEXICO | 2015年 / 85卷 / 02期

关键词：

Human immunodeficiency virus; Pulmonary Arterial Hypertension; AIDS; Mexico;

D O I：

10.1016/j.acmx.2014.10.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

From the advent of the highly effective antiretroviral treatment, the life expectancy of patients with human immunodeficiency virus has increased significantly. At present, the causes of death are non-infectious complications. Between them, the pulmonary arterial hypertension has a special importance. It is important early detection to establish the therapeutic, with the objective of preventing a fatal outcome to future. (C) 2013 Instituto Nacional de Cardiologia Ignacio Chavez. Published by Masson Doyma Mexico S.A. All rights reserved.

引用

页码：118 / 123

页数：6

共 37 条

[1] Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension
Aguilar, RV
Farber, HW
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) : 1846 - 1850
[2] Sildenafil in the treatment of pulmonary hypertension
Barnett, Christopher F.
Machado, Roberto F.
[J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (04) : 411 - 422
[3] Human Immunodeficiency Virus-Associated Pulmonary Arterial Hypertension
Barnett, Christopher F.
Hsue, Priscilla Y.
[J]. CLINICS IN CHEST MEDICINE, 2013, 34 (02) : 283 - +
[4] Treatment of HIV-associated pulmonary hypertension with treprostinil
Cea-Calvo, L
Subías, PE
de Menesses, RT
Salvador, ML
Sánchez, MAG
Jiménez, JFD
Rodríguez, CP
Cano, MJR
de la Calzada, CS
[J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (04): : 421 - 425
[5] Comprehensive Invasive and Noninvasive Approach to the Right Ventricle-Pulmonary Circulation Unit State of the Art and Clinical and Research Implications
Champion, Hunter C.
Michelakis, Evangelos D.
Hassoun, Paul M.
[J]. CIRCULATION, 2009, 120 (11) : 992 - 1007
[6] Cicalini S, 2011, EXPERT REV RESP MED, V5, P257, DOI [10.1586/ERS.11.10, 10.1586/ers.11.10]
[7] Expression of human herpesvirus 8 in primary pulmonary hypertension
Cool, CD
Rai, PR
Yeager, ME
Hernandez-Saavedra, D
Serls, AE
Bull, TM
Geraci, MW
Brown, KK
Routes, JM
Tuder, RM
Voelkel, NF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) : 1113 - 1122
[8] Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
Degano, B.
Yalci, A.
Le Pavec, J.
Savale, L.
Jais, X.
Camara, B.
Humbert, M.
Simonneau, G.
Sitbon, O.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (01) : 92 - 98
[9] HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era
Degano, Bruno
Guillaume, Mathilde
Savale, Laurent
Montani, David
Jais, Xavier
Yaici, Azzedine
Le Pavec, Jerome
Humbert, Marc
Simonneau, Gerald
Sitbon, Olivier
[J]. AIDS, 2010, 24 (01) : 67 - 75
[10] Immunopathogenic mechanisms of HIV infection
Fauci, AS
Pantaleo, G
Stanley, S
Weissman, D
[J]. ANNALS OF INTERNAL MEDICINE, 1996, 124 (07) : 654 - 663

← 1 2 3 4 →